Effect of estrogen receptor beta expression (ERβe) in triple-negative breast cancer (TNBC) patients treated in the neoadjuvant GeparTrio trial.

被引：0
|
作者：
Heitz, F.
Sinn, B.
Loibl, S.
Du Bois, A.
Jackisch, C.
Kuemmel, S.
Denkert, C.
Barinoff, J.
Mehta, K.
Von Minckwitz, G.
机构：
[1] Klinken Essen Mitte, Dept Gynecol & Gynecol Oncol, Wiesbaden, Germany
[2] Charite, D-13353 Berlin, Germany
[3] German Breast Grp, Neulsenburg, Germany
[4] Kliniken Essen Mitte, Essen, Germany
[5] Klinikum Offenbach, Offenbach, Germany
[6] Canc Ctr Essen, Breast Unit, Essen, Germany
[7] Klinken Essen Mitte, Dept Gynecol & Gynecol Oncol, Essen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.1069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1069
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The predictive role of estrogen receptor beta (ER-β) in androgen receptor (AR)-positive triple-negative breast cancer (TNBC)
    Anestis, A.
    Mihailidou, C.
    Theocharis, S.
    Tryfonopoulos, D.
    Korogiannos, A.
    Koumarianou, A.
    Xingi, E.
    Kontos, M.
    Papavassiliou, A. G.
    Karamouzis, M. V.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] ANDROGEN-RECEPTOR EXPRESSION IN TRIPLE NEGATIVE BREAST CANCER: RESULTS FROM THE NEOADJUVANT GEPARTRIO TRIAL
    Loibl, S.
    Mueller, B. M.
    Roller, M.
    Darb-Esfahani, S.
    von Minckwitz, G.
    Denkert, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 45 - 45
  • [3] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [4] Androgen-receptor expression in triple negative breast cancer: Results from the neoadjuvant GeparTrio trial
    Loibl, Sibylle
    Muller, Berit
    Roller, Marc
    Darb-Esfahani, Silvia
    von Minckwitz, Gunter
    Denkert, Carsten
    CANCER RESEARCH, 2009, 69
  • [5] Prognostic effect of beta blockers (BB) in triple-negative breast cancer (TNBC) patients
    Munzone, Elisabetta
    Botteri, Edoardo
    Rotmensz, Nicole
    Cipolla, Carlo Maria
    Zanelotti, Arnaldo
    Adamoli, Laura
    Viale, Giuseppe
    Goldhirsch, Aron
    Gandini, Sara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Estrogen receptor beta expression in triple negative breast cancer
    Choi, Y.
    HISTOPATHOLOGY, 2008, 53 : 30 - 31
  • [7] PARTNER Trial: Neoadjuvant olaparib in triple negative breast cancer (TNBC)
    Abraham, Jean E.
    Pinilla, Karen
    Grybowicz, Louise
    Dayimu, Alimu
    Demiris, Nikolaos
    Harvey, Caron
    Drewett, Lynsey M.
    Lucey, Rebecca
    Fulton, Alexander
    Roberts, Anne N.
    Worley, Joanna R.
    Chhabra, Anita
    Qian, Wendi
    Hardy, Richard M.
    Chan, Stephen
    Hickish, Tamas
    Tripathi, Devashish
    Venkitaraman, Ramachandran
    Persic, Mojca
    Aslam, Shahzeena
    Glassman, Daniel
    Raj, Sanjay
    Borley, Annabel
    Braybrooke, Jeremy P.
    Sutherland, Stephanie
    Staples, Emma
    Scott, Lucy C.
    Davies, Mark
    Palmer, Cheryl A.
    Moody, Margaret
    Churn, Mark J.
    Newby, Jacqueline C.
    Mukesh, B. Mukesh
    Chakrabarti, Amitabha
    Roylance, Rebecca R.
    Schouten, Philip C.
    Levitt, Nicola
    McAdam, Karen
    Armstrong, Anne C.
    Copson, Ellen R.
    McMurtry, Emma
    Tischkowitz, Marc
    Provenzano, Elena
    Earl, Helena
    CANCER RESEARCH, 2024, 84 (07)
  • [8] Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer
    Guo, Liying
    Zhu, Qianwen
    Aisimutuola, Mulati
    Yilamu, Dilimina
    Liu, Sha
    Jakulin, Adina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (06) : 2147 - 2150
  • [9] Expression of SPARC in human breast cancer and its predictive value in the GeparTrio neoadjuvant trial.
    Untch, M.
    Prinzler, J.
    Fasching, P.
    Mueller, B. M.
    Gade, S.
    Meinhold-Heerlein, I.
    Huober, J.
    Karn, T.
    Liedtke, C.
    Loibl, S.
    Mueller, V.
    Rack, B.
    Schem, C.
    Darb-Esfahani, S.
    von Minckwitz, G.
    Denkert, C.
    CANCER RESEARCH, 2012, 72
  • [10] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345